Protalix BioTherapeutics (PLX) EBT Margin Growth (5y) (2015 - 2026)
Protalix BioTherapeutics (PLX) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,442.00 |
| Dec 31, 2025 | -7,003.00 |
| Sep 30, 2025 | 5,476.00 |
| Jun 30, 2025 | 4,241.00 |
| Mar 31, 2025 | -4,367.00 |
| Dec 31, 2024 | 6,433.00 |
| Sep 30, 2024 | 4,662.00 |
| Jun 30, 2024 | 4,639.00 |
| Mar 31, 2024 | -5,488.00 |
| Dec 31, 2023 | 12,261.00 |
| Sep 30, 2023 | 82,079.00 |
| Jun 30, 2023 | 35,746.00 |
| Mar 31, 2023 | 13,127.00 |
| Dec 31, 2022 | 61,958.00 |
| Sep 30, 2022 | 12,692.00 |
| Jun 30, 2022 | 15,690.00 |
| Mar 31, 2022 | 66,576.00 |
| Dec 31, 2021 | -60,713.00 |
| Sep 30, 2021 | 12,621.00 |
| Jun 30, 2021 | 43,543.00 |